| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| QNCX | Quince Therapeutics, Inc. | Hannah Brendan | Chief Business Officer | Aug 08, 2023 | Buy | $1.22 | 71,762 | 87,550 | 201,555 | Aug 09, 2023, 06:21 PM |
Menu
| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| QNCX | Quince Therapeutics, Inc. | Hannah Brendan | Chief Business Officer | Aug 08, 2023 | Buy | $1.22 | 71,762 | 87,550 | 201,555 | Aug 09, 2023, 06:21 PM |